RADICALS-HD trial: androgen deprivation therapy with post-operative radiotherapy to treat prostate cancer
RADICALS-HD trial: androgen deprivation therapy with post-operative radiotherapy to treat prostate cancer
Extended adjuvant AI not advised for HPBC after 5+ yrs of sequential endocrine therapy
Atezolizumab added to chemo fails to improve PFS in relapsed ovarian cancer
Treatment with tumour-infiltrating lymphocytes versus ipilimumab significantly improved PFS for advanced melanoma
WCLC 2022: Highlights
OncoAlert and ecancer weekly round up for August 15th - 21st, 2022
An overview of treatment advances in gastric cancer
Working to improve global cancer care access in low middle-income countries
Impact of BRAF-V600E mutation on the tumour microenvironment and associated genomic alterations in colorectal cancer
ASCO Direct Highlights 2022: lung cancer highlights
Locally and advanced immunotherapy developments and new agents in lung cancer
The advances in the management of patients with Hodgkin lymphoma and non-Hodgkin lymphoma